Provider
Insurers have historically looked at claims data to determine a member's health needs.
A recent small study published in Nature’s Translational Psychiatry journal observed a change in the brain networking and behavior of boys receiving a video game-based treatment for ADHD.
ReMix, a new technology in the works at MIT's Computer Science and Artificial Intelligence Laboratory, seeks to make progress toward a new paradigm of treatment – one that's less reliant on endoscopy and surgery, but instead relies on sensors and what scientists call an "in-body GPS" to help make diagnoses and guide drug administration.
The Facebook-affliated research group partners with universities to study machine learning and artificial intelligence.
Deborah Kilpatrick has spent some time on the cutting edge of the healthcare industry — her decade-spanning career has included a director position at Guidant Corporation’s vascular intervention accelerator (now part of Boston Scientific) and the chief commercial officer role at genomic diagnostic company CardioDx.
A new tele-pharmacy 'super-hub' is set to help people living with chronic conditions and create 30 new jobs in Liverpool.
Healthy Interactions, a population health company that offers both digital and in-person programs for chronic disease management and education, and Merck have launched a diabetes management and engagement platform designed to support in-person counseling programs.
A recent study published in JAMA Surgery found that when it comes to reporting conflicts of interest in regards to compensation from medical device companies, doctors aren’t always completely forthcoming.
Editor's note: This article has been updated to clarify FDA classification of the Sprint Peripheral Nerve Stinulation system.
While having a digital companion or tracker can help folks on their weight loss or maintenance journey, dieters may get the best results if they use the technology as part of an intradisciplinary approach to weight loss, according to a recent review published in Current Opinion in Endocrinology, Diabetes, and Obesity.